Results 201 to 210 of about 247,999 (295)

Computational Studies toward the Identification of CB2R-M1R Dual Modulators. [PDF]

ACS Omega
Isawi IH, Al-Zoubi R, Hajjo R, Obeidat RM, AlKhawaldeh IH, Al Kilani OM, Alhaj Hasan MJ, Morales P.   +7 more
europepmc   +1 more source

A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects

Neuropsychopharmacology, 2015
Bogna Marta Ignatowska-Jankowska, G. Baillie, S. Kinsey, M. Crowe, Sudeshna Ghosh, R. A. Owens, I. Damaj, J. Poklis, J. Wiley, M. Zanda, C. Zanato, I. Greig, A. Lichtman, R. Ross   +13 more
semanticscholar   +1 more source

Editorial: Neurobiological basis of substance use disorders: new findings and perspectives. [PDF]

Front Neurosci
Favoretto CA, Loss CM, Vozella V, Cruz FC.   +3 more
europepmc   +1 more source

Cannabinoid Signaling and Autophagy in Oral Disease: Molecular Mechanisms and Therapeutic Implications. [PDF]

Int J Mol Sci
Munkhsaikhan U, Rahman MA, Shasteen A, Ait-Aissa K, Sahyoun AM, Gupta RD, Kassan M, Hoque Apu E, Abidi AH.   +8 more
europepmc   +1 more source

Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor

Proceedings of the National Academy of Sciences of the United States of America, 2012
F. Pamplona, J. Ferreira, Octávio Menezes de Lima, F. S. Duarte, A. Bento, S. Forner, J. G. Villarinho, L. Bellocchio, C. Wotjak, Raissa Lerner, K. Monory, B. Lutz, C. Canetti, I. Matias, J. Calixto, G. Marsicano, M. Guimarães, R. Takahashi   +17 more
semanticscholar   +1 more source

Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies. [PDF]

Diseases
Afonso S, Gonçalves J, Brinca AT, Rosendo LM, Rosado T, Duarte AP, Gallardo E.   +6 more
europepmc   +1 more source

CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity

Molecular Pharmacology, 2013
G. Baillie, J. G. Horswill, Sharon Anavi-Goffer, P. Reggio, D. Bolognini, M. Abood, Sean D McAllister, P. G. Strange, G. Stephens, R. Pertwee, R. Ross   +10 more
semanticscholar   +1 more source

Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review. [PDF]

Pharmaceuticals (Basel)
Marques BL, Lirio PHC, Vicente MA, Unzueta-Larrinaga P, Urigüen L, Campos AC.   +5 more
europepmc   +1 more source

Enhanced endocannabinoid signaling modulates neuronal network dynamics in the hippocampus [PDF]

, 2018
Stepan, Jens
core   +1 more source

Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis. [PDF]

HRB Open Res
Lane RM, Egan LJ, McGuire BE, McKernan DP, O'Mahony SM, Finn DP.   +5 more
europepmc   +1 more source